Home » Stocks » Nevro Corp.

Nevro Corp. (NVRO)

Stock Price: $134.02 USD -0.71 (-0.52%)
Updated Aug 11, 2020 11:30 AM EDT - Market open

Stock Price Chart

Key Info

Market Cap 4.60B
Revenue (ttm) 358.39M
Net Income (ttm) -97.54M
Shares Out 34.31M
EPS (ttm) -3.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 11, 2020
Last Price $134.02
Previous Close $134.72
Change ($) -0.71
Change (%) -0.52%
Day's Open 135.10
Day's Range 131.75 - 135.11
Day's Volume 40,669
52-Week Range 61.77 - 148.05

More Stats

Market Cap 4.60B
Enterprise Value 4.36B
Earnings Date (est) Nov 9, 2020
Ex-Dividend Date n/a
Shares Outstanding 34.31M
Float 31.77M
EPS (basic) -3.01
EPS (diluted) -3.05
FCF / Share -1.26
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 2.82M
Short Ratio 7.64
Short % of Float 9.53%
Beta 0.94
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 12.83
PB Ratio 12.99
Revenue 358.39M
Operating Income -86.09M
Net Income -97.54M
Free Cash Flow -42.94M
Net Cash 242.85M
Net Cash / Share 7.08
Gross Margin 74.88%
Operating Margin -24.02%
Profit Margin -27.20%
FCF Margin -11.98%
ROA -8.79%
ROE -33.87%
ROIC -16.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (13)

Buy 10
Overweight 0
Hold 3
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$154.00*
(14.91% upside)
Low
139
Current: $134.02
High
170
Target: 154.00
*Average 12-month price target from 10 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015201420132012
Revenue39038732722969.6132.5723.5018.15
Revenue Growth0.77%18.56%42.96%228.28%113.69%38.61%29.48%-
Gross Profit26827322815341.4921.3014.0310.62
Operating Income-96.48-41.74-29.58-23.08-62.37-28.31-25.15-19.13
Net Income-104-49.21-36.66-31.78-67.43-30.68-26.01-18.97
Shares Outstanding30.8030.0529.4228.4926.584.440.880.49
Earnings Per Share-3.37-1.64-1.25-1.12-2.54-6.94-29.84-38.59
Operating Cash Flow-50.23-5.71-14.27-58.50-100-31.15-21.10-22.47
Capital Expenditures-3.47-8.22-4.33-3.37-5.01-0.63-0.06-0.03
Free Cash Flow-53.70-13.93-18.60-61.87-105-31.77-21.15-22.50
Cash & Equivalents23926527027719517756.8356.83
Total Debt18115214513819.7419.51--
Net Cash / Debt58.0111312513917515856.8356.83
Assets47046345443129120275.4175.41
Liabilities25321820518256.5930.437.977.97
Book Value216245249249235172-85.79-85.79
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Nevro Corp.
Country United States
Employees 853
CEO D. Keith Grossman

Stock Information

Ticker Symbol NVRO
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Devices
Unique Identifier NYSE: NVRO
IPO Date November 6, 2014

Description

Nevro Corp., a medical device company, provides products for the patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. It also offers Senza II system and Senza Omnia system products for chronic pain. The company's solution for chronic pain also includes HF10 Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. Nevro Corp. sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was founded in 2006 and is headquartered in Redwood City, California.